GAITHERSBURG, Md., Sept. 29, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
WOBURN, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL;…
Collaborative research utilized insights gained from CENTOGENE’s rare disease-centric Bio/Databank to help analyze data of…
SAN DIEGO, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE”…
REDWOOD CITY, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — It is with profound sadness that…
GENFIT Reports First Half-Year 2021 Financial Results and Provides Corporate Update Financial highlights Cash and…
COPENHAGEN, Denmark, Sept. 29, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
EMERYVILLE, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage…
ANAHEIM, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
Management board of the joint stock company “Olainfarm”, registration No 40003007246, registered address: Rūpnīcu iela…
Guerbet contributes to the NH TherAguix IPO on Euronext Growth, a specialist in innovative biotechnologies…
TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
Sandusky, OH, Sept. 29, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) has…
The project will engage the community to build the definitive reference set of the human…
Lomecel-B significantly decreased biomarker Tie-2 in Aging Frailty subjects at 270 days compared to placebo…
Company honored at 6th Annual Massachusetts Legislative Manufacturing Caucus Awards ceremony LAUPHEIM, Germany and MILFORD,…
EDISON, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
Denali to present results from Phase 1 healthy volunteer study of EIF2B activator DNL343 Sanofi…
No serious adverse events or dose-limiting toxicities observed to date Efficacy signals in the mid-dose…